Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer

Por Jimenez, Camilo
Publicado no Front Endocrinol (Lausanne) (2018)

Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors

Por Toledo, Rodrigo, Jimenez, Camilo
Publicado no F1000Res (2018)

Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies

Por Gómez, Karen, Varghese, Jeena, Jiménez, Camilo
Publicado em 2011

Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat—and With Which Drug—Those Are the Questions

Por Cabanillas, Maria E., Hu, Mimi I., Jimenez, Camilo
Publicado no J Clin Endocrinol Metab (2014)

Pheochromocytoma in Urologic Practice

Por Waingankar, Nikhil, Bratslavsky, Gennady, Jimenez, Camilo, Russo, Paul, Kutikov, Alexander
Publicado no Eur Urol Focus (2016)

A Novel SDHB Mutation Associated with Hereditary Head and Neck Paraganglioma

Por Peck, Brandon W., Rich, Thereasa A., Jimenez, Camilo, Kupferman, Michael E.
Publicado em 2011

Treating medullary thyroid cancer in the age of targeted therapy

Por Cabanillas, Maria E, Hu, Mimi I, Jimenez, Camilo, Grubbs, Elizabeth G, Cote, Gilbert J
Publicado no Int J Endocr Oncol (2014)

Genetic Testing in Head and Neck Paraganglioma: Who, What, and Why?

Por Sridhara, Shankar K., Yener, Murat, Hanna, Ehab Y., Rich, Thereasa, Jimenez, Camilo, Kupferman, Michael E.
Publicado em 2013

Mitotane-Induced Hyperlipidemia: A Retrospective Cohort Study

Por Shawa, Hassan, Deniz, Ferhat, Bazerbashi, Hadil, Hernandez, Mike, Vassilopoulou-Sellin, Rena, Jimenez, Camilo, Habra, Mouhammed Amir
Publicado em 2013

Malignant head and neck paragangliomas: Is there an optimal treatment strategy?

Por Moskovic, Daniel J, Smolarz, Joseph R, Stanley, Douglas, Jimenez, Camilo, Williams, Michelle D, Hanna, Ehab Y, Kupferman, Michael E
Publicado em 2010

[(18)F]Fluorodeoxyglucose Positron Emission Tomography–Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case

Por Chuang, Hubert H., Deniz, Ferhat, Sircar, Kanishka, Jimenez, Camilo, Rubin De Celis, Carlos, Wood, Christopher G., Habra, Mouhammed Amir
Publicado em 2012

Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case report

Por Noreña, Jairo Arturo, Niño, César Daniel, Gallego, Sabrina, Builes-Barrera, Carlos Alfonso, Castro, Diva Cristina, Román-González, Alejandro, Jimenez, Camilo
Publicado no Clin Cases Miner Bone Metab (2017)

Review of Immune-Related Adverse Events in Prostate Cancer Patients Treated with Ipilimumab: MD Anderson Experience

Por Gao, Jianjun, He, Qiuming, Subudhi, Sumit, Aparicio, Ana, Zurita-Saavedra, Amado, Lee, Da Hyun, Jimenez, Camilo, Suarez-Almazor, Maria, Sharma, Padmanee
Publicado no Oncogene (2015)

Clinical Benefits of Systemic Chemotherapy for Patients with Metastatic Pheochromocytomas or Sympathetic Extra-Adrenal Paragangliomas: Insights from the Largest Single Institutiona...

Por Ayala-Ramirez, Montserrat, Feng, Lei, Habra, Mouhammed A., Rich, Thereasa, Dickson, Paxton V., Perrier, Nancy, Phan, Alexandria, Waguespack, Steven, Patel, Shreyaskumar, Jimenez, Camilo
Publicado em 2011

Bone Metastases and Skeletal-Related Events in Patients With Malignant Pheochromocytoma and Sympathetic Paraganglioma

Por Ayala-Ramirez, Montserrat, Palmer, J. Lynn, Hofmann, Marie-Claude, de la Cruz, Maxine, Moon, Bryan S., Waguespack, Steven G., Habra, Mouhammed Amir, Jimenez, Camilo
Publicado no J Clin Endocrinol Metab (2013)

Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T Mutation

Por Jasim, Sina, Ying, Anita K., Waguespack, Steven G., Rich, Thereasa A., Grubbs, Elizabeth G., Jimenez, Camilo, Hu, Mimi I., Cote, Gilbert, Habra, Mouhammed Amir
Publicado em 2011

The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2

Por Thosani, Sonali, Ayala-Ramirez, Montserrat, Palmer, Lynn, Hu, Mimi I., Rich, Thereasa, Gagel, Robert F., Cote, Gilbert, Waguespack, Steven G., Habra, Mouhammed Amir, Jimenez, Camilo
Publicado no J Clin Endocrinol Metab (2013)

Cushing's syndrome secondary to ectopic ACTH secretion: The University of Texas MD Anderson Cancer Center Experience

Por Ejaz, Shamim, Vassilopoulou-Sellin, Rena, Busaidy, Naifa L., Hu, Mimi I., Waguespack, Steven G., Jimenez, Camilo, Ying, Anita K., Cabanillas, Maria, Abbara, Maher, Habra, Mouhammed Amir
Publicado em 2011

Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer

Por Dadu, Ramona, Waguespack, Steven G., Sherman, Steven I., Hu, Mimi I., Busaidy, Naifa L., Jimenez, Camilo, Habra, Mohammed A., Ying, Anita K., Bassett, Roland L., Cabanillas, Maria E.
Publicado em 2014

Impact and Timing of Bilateral Adrenalectomy for Refractory ACTH-Dependent Cushing’s Syndrome

Por Morris, Lilah F., Harris, Rachel S., Milton, Denái R., Waguespack, Steven G., Habra, Mouhammed A., Jimenez, Camilo, Vassilopoulou-Sellin, Rena, Lee, Jeffrey E., Perrier, Nancy D., Grubbs, Elizabeth G.
Publicado no Surgery (2013)